Semaglutide.
Weekly GLP-1 receptor agonist for appetite control and metabolic recalibration.
What Semaglutide does.
Clinical effects most commonly reported. Individual response varies — your physician sets the appropriate cycle and dose.
- Quiets the appetite curve and slows gastric emptying
- Steady weekly bodyweight loss in the 0.5–1.5% range when paired with training
- Improves glycemic control and insulin sensitivity
- Subcutaneous injection — once weekly
Semaglutide is a GLP-1 receptor agonist used for fat loss, appetite regulation, and metabolic support. Most clients start here before moving to Tirzepatide if response plateaus.
Get Semaglutide.
Start an inquiry, or send a question first.
Prescription products require a consultation with a licensed clinician through our independent clinical partner. Compounded medications are not FDA-approved, and statements about them have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Consult your physician before starting any protocol. Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies.